VENLAFAXINE XR 75mg Capsules Recalled Due to Dissolution Issues
Pro-Doc Ltée. is recalling one lot of VENLAFAXINE XR extended-release capsules because the product's dissolution was found to be out of specification.
What Happened
Pro-Doc Ltée. has initiated a recall for a specific batch of VENLAFAXINE XR 75mg capsules. The recall was issued because the dissolution rate of the medication in the affected lot is out of specification, which may affect how the drug is released and absorbed in the body.
Which Products Are Affected
The recall involves the following product:
- Product Name: VENLAFAXINE XR (Venlafaxine Hydrochloride)
- Strength: 75mg
- Dosage Form: Capsule (extended release)
- DIN (Drug Identification Number): 02339250
- Lot Number: 2505003230
- Company: Pro-Doc Ltée., located at 2925 boul. Industriel, Laval, Qc, H7L 3W9.
What You Should Do
Consumers are advised to verify if their product is part of the affected lot. Before discontinuing the use of the medication, you must consult your healthcare provider, as stopping this type of medication abruptly can have health implications. For questions regarding the recall, contact Pro-Doc Ltée. directly. Any health product-related side effects or safety complaints should be reported to Health Canada.
Why This Matters
When a medication’s dissolution is out of specification, it means the drug may not dissolve at the intended rate. This can lead to inconsistent levels of the medication in the patient’s system, potentially reducing the drug’s effectiveness or increasing the risk of side effects.
Source
Source: Health Canada Official Notice